Effect of SmtO2 Guided Care on PONV (iMODIPONV) (iMODIPONV)
Primary Purpose
Postoperative Nausea and Vomiting, Hysterectomy, Tissue Oxygenation
Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Muscular tissue oxygen saturation guided care
Sponsored by
About this trial
This is an interventional prevention trial for Postoperative Nausea and Vomiting focused on measuring Postoperative Nausea and Vomiting, Laparoscopic Hysterectomy, Muscular Tissue Oxygen Saturation, Hemodynamic Management
Eligibility Criteria
Inclusion Criteria:
- Age 18-65 years
- Non-smoker
- ASA I-III
- Elective laparoscopic procedure involving hysterectomy
Exclusion Criteria:
- Refuse to participate
- Emergent surgery
- Bowel resection planned
- Vaginal or abdominal (open) hysterectomy
- Chemotherapy or radiotherapy before surgery
- Significant neuro, cognitive, or psychologic disease: stroke with neurologic deficit, dementia, schizophrenia, or any condition that makes meaningful postoperative follow-ups impossible
- Significant cardiovascular disease: low-output cardiac failure defined as a preoperative left ventricular ejection fraction < 30%, active coronary artery disease, symptomatic valvular disease, symptomatic arrhythmia with or without pacemaker and/or AICD placement
- Significant pulmonary disease: COPD requiring home oxygen therapy, severe asthma requiring steroid treatment, other pulmonary conditions requiring home oxygen therapy
- Severe hepatic dysfunction being evaluated for liver transplantation or with a Child-Pugh Class C classification
- Severe renal dysfunction requiring renal replacement therapy
- Muscular pathologies such as dystrophy, atrophy, and weakness
- Skin conditions incompatible with the adhesive oximetry probe (e.g., delicate or tattooed skin)
- Current or previous smoker
- ASA Physical Score ≥ IV
Sites / Locations
- Peking University Third Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Intervention
Control
Arm Description
In addition to usual care during surgery, the intraoperative management will be additionally managed based on the guidance of muscular tissue oxygen saturation and non-invasive hemodynamic monitoring.
Patients will receive the usual care. Muscular tissue oxygen saturation and non-invasive hemodynamic monitoring will be used but blinded to care givers.
Outcomes
Primary Outcome Measures
Incidence of PONV within 24 hours after surgery
Nausea: Nausea is defined as a subjective unpleasant sensation associated with the urge to vomit.
Retching: Retching is defined as the labored, spastic, and rhythmic contraction of chest and abdominal muscles without expulsion of gastric contents.
Vomiting: Vomiting is defined as the forceful expulsion of any gastric contents from the mouth.
PONV: PONV refers to the occurrence of nausea, retching, and/or vomiting.
Secondary Outcome Measures
Incidence of early PONV
The incidence of PONV during postoperative 0-6 hours. The diagnostic criteria for early PONV are the same as above (outcome 1).
Severity of postoperative pain
Postoperative pain intensity at rest and with movement expressed using NRS 0-10 (0 = no pain; 10 = worst pain) at 2, 6, and 24 h depending on the time to discharge
Time of GI recovery
Time to GI recovery (time to first flatus, bowel motion, and/or time to tolerate oral diet, in hours)
Overall quality of recovery based on QoR-15 questionnaire
Postoperative quality of recovery
(using the QoR-15 questionnaire)
QoR-15 Questions PART A How have you been feeling in the last 24 hours? (0 to 10, where 0 = none of the time [poor] and 10 = all of the time [excellent] Q.1 Able to breathe easily Q.2 Been able to enjoy food Q.3 Feeling rested Q.4 Have had a good sleep Q.5 Able to look after personal toilet and hygiene unaided Q.6 Able to communicate with family or friends Q.7 Getting support from hospital doctors and nurses Q.8 Able to return to work or usual home activities Q.9 Feeling comfortable and in control Q.10 Having a feeling of general well-being PART B Have you had any of the following in the last 24 hours? (10 to 0, where 10 = none of the time [excellent] and 0 = all of the time [poor]) Q.11 Moderate pain Q.12 Severe pain Q.13 Nausea or vomiting Q.14 Feeling worried or anxious Q.15 Feeling sad or depressed
Time to mobilization
Time to mobilization (time to first out-of-bed mobilization, in hours)
Score of sleep quality
Postoperative sleep quality (using NRS 0-10 (0 = no concern at all; 10 = worst ever) for the first night or the second night if the case is finished after 6pm)
In-hospital GI complications
In-hospital GI-related composite complication (composite of ileus, obstruction, perforation, and bleeding)
Non-GI-related composite complications
Both in-hospital and 30-day non-GI-related composite complications (Complication was defined as any deviation from the normal postoperative course or organ dysfunction.[23-25] Organ-specific complications include myocardial infarction, congestive heart failure, cardiac arrest, atrial fibrillation or other types of arrhythmia, pulmonary embolus, pneumonia treated with antibiotics, respiratory failure requiring intubation, respiratory insufficiency requiring physiotherapy or oxygen therapy, stroke, transient ischemic attack, postoperative delirium or cognitive decline, renal insufficiency requiring dialysis, acute kidney injury, urinary tract infection requiring antibiotics, hepatic insufficiency, gut hypoperfusion, ileus, disseminated intravascular coagulation, and sepsis. Surgery-related complications refer to surgical site bleeding, infection, anastomotic leakage, stenosis, ischemia, or tissue necrosis.)
Length of hospital stay
Length of hospital stay, in days
Rate of ICU admission
The percentage of patients admitted to ICU after surgery
30-day mortality
30-day mortality
Full Information
NCT ID
NCT03641625
First Posted
July 27, 2018
Last Updated
September 23, 2019
Sponsor
Yale University
Collaborators
The Second Hospital of Hebei Medical University, Peking University First Hospital, Peking University Third Hospital, Shandong Provincial Hospital, The First Affiliated Hospital of Zhengzhou University, Beijing Obstetrics and Gynecology Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03641625
Brief Title
Effect of SmtO2 Guided Care on PONV (iMODIPONV)
Acronym
iMODIPONV
Official Title
Effect of Muscular Tissue Oxygen Saturation-Guided Management During Laparoscopic Hysterectomy on Postoperative Nausea and Vomiting: A Randomized Controlled Trial (iMODIPONV)
Study Type
Interventional
2. Study Status
Record Verification Date
September 2019
Overall Recruitment Status
Completed
Study Start Date
September 15, 2018 (Actual)
Primary Completion Date
June 29, 2019 (Actual)
Study Completion Date
July 31, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Yale University
Collaborators
The Second Hospital of Hebei Medical University, Peking University First Hospital, Peking University Third Hospital, Shandong Provincial Hospital, The First Affiliated Hospital of Zhengzhou University, Beijing Obstetrics and Gynecology Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This randomized controlled trial is to investigate if SmtO2-guided management on top of the usual care, compared with the usual care only, during laparoscopic hysterectomy significantly reduces the incidence of PONV.
Detailed Description
Postoperative nausea and vomiting (PONV) remains prevalent despite the institution of various prophylactic measures. The incidence of PONV in female patients undergoing laparoscopic gynecological surgery is up to 50% with and 70% without the administration of antiemetics, respectively. The consequences of PONV range from patient discomforts, postoperative complications, prolonged hospitalization, to increased health care costs. Among the multiple risk factors, suboptimal gastrointestinal (GI) perfusion or oxygenation may be responsible for some cases of PONV; however, this speculation remains to be confirmed.5 Optimal tissue oxygenation, the balance between tissue oxygen consumption and supply, is essential for the integrity of any tissue bed that is metabolically active. However, GI oxygenation cannot be directly and continuously monitored in patients at this time. Whether there is an organ which can be used as a surrogate of the GI system, meaning that the tissue oxygenation of this surrogate organ not only can be monitored and that it also correlates with that of the GI system, is an intriguing question. Currently, tissue oxygenation can be measured using near-infrared spectroscopy (NIRS) in patients. The recent advancements of this technology enable the accurate monitoring of the oxygenation within many tissue beds depending on the location of the oximetry probe.
The recent cohort study demonstrated that there is a close relationship between muscular tissue oxygen saturation (SmtO2) and PONV in patients undergoing robotic laparoscopic hysterectomy (manuscript accepted and in production). Multiple thresholds based on threshold, AUC, and multivariable analyses are able to differentiate the risk of PONV. The following SmtO2 thresholds were found to correlate with a reduced risk of PONV: 20% above baseline; while the following thresholds correlate with an increased risk of PONV: 5% below baseline, 15% below baseline, and 20% below baseline, < 70%, < 65%, and < 60%. Taken together, our study suggests the potential therapeutic targets for PONV prophylaxis may be to maintain SmtO2 > 70% and above baseline.
In this study, the investigators aim to investigate if intraoperative care guided by SmtO2 monitoring reduces the incidence of PONV after laparoscopic hysterectomy.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Nausea and Vomiting, Hysterectomy, Tissue Oxygenation, Cardiac Output Management, Blood Pressure Management
Keywords
Postoperative Nausea and Vomiting, Laparoscopic Hysterectomy, Muscular Tissue Oxygen Saturation, Hemodynamic Management
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
International, multi-center, pragmatic, randomized controlled (1:1 ratio) trial
Masking
ParticipantOutcomes Assessor
Masking Description
Both patients and outcomes assessor are blinded to group assignment.
Allocation
Randomized
Enrollment
800 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
In addition to usual care during surgery, the intraoperative management will be additionally managed based on the guidance of muscular tissue oxygen saturation and non-invasive hemodynamic monitoring.
Arm Title
Control
Arm Type
No Intervention
Arm Description
Patients will receive the usual care. Muscular tissue oxygen saturation and non-invasive hemodynamic monitoring will be used but blinded to care givers.
Intervention Type
Device
Intervention Name(s)
Muscular tissue oxygen saturation guided care
Intervention Description
Muscular tissue oxygen saturation monitored at flank and arm will be maintained > 70% (absolute measurement) and > baseline throughout the entire procedure.
Primary Outcome Measure Information:
Title
Incidence of PONV within 24 hours after surgery
Description
Nausea: Nausea is defined as a subjective unpleasant sensation associated with the urge to vomit.
Retching: Retching is defined as the labored, spastic, and rhythmic contraction of chest and abdominal muscles without expulsion of gastric contents.
Vomiting: Vomiting is defined as the forceful expulsion of any gastric contents from the mouth.
PONV: PONV refers to the occurrence of nausea, retching, and/or vomiting.
Time Frame
up to 24 hours
Secondary Outcome Measure Information:
Title
Incidence of early PONV
Description
The incidence of PONV during postoperative 0-6 hours. The diagnostic criteria for early PONV are the same as above (outcome 1).
Time Frame
up to 6 hours
Title
Severity of postoperative pain
Description
Postoperative pain intensity at rest and with movement expressed using NRS 0-10 (0 = no pain; 10 = worst pain) at 2, 6, and 24 h depending on the time to discharge
Time Frame
up to 24 hours
Title
Time of GI recovery
Description
Time to GI recovery (time to first flatus, bowel motion, and/or time to tolerate oral diet, in hours)
Time Frame
up to 48 hours
Title
Overall quality of recovery based on QoR-15 questionnaire
Description
Postoperative quality of recovery
(using the QoR-15 questionnaire)
QoR-15 Questions PART A How have you been feeling in the last 24 hours? (0 to 10, where 0 = none of the time [poor] and 10 = all of the time [excellent] Q.1 Able to breathe easily Q.2 Been able to enjoy food Q.3 Feeling rested Q.4 Have had a good sleep Q.5 Able to look after personal toilet and hygiene unaided Q.6 Able to communicate with family or friends Q.7 Getting support from hospital doctors and nurses Q.8 Able to return to work or usual home activities Q.9 Feeling comfortable and in control Q.10 Having a feeling of general well-being PART B Have you had any of the following in the last 24 hours? (10 to 0, where 10 = none of the time [excellent] and 0 = all of the time [poor]) Q.11 Moderate pain Q.12 Severe pain Q.13 Nausea or vomiting Q.14 Feeling worried or anxious Q.15 Feeling sad or depressed
Time Frame
up to 24 hours
Title
Time to mobilization
Description
Time to mobilization (time to first out-of-bed mobilization, in hours)
Time Frame
up to 48 hours
Title
Score of sleep quality
Description
Postoperative sleep quality (using NRS 0-10 (0 = no concern at all; 10 = worst ever) for the first night or the second night if the case is finished after 6pm)
Time Frame
up to 48 hours
Title
In-hospital GI complications
Description
In-hospital GI-related composite complication (composite of ileus, obstruction, perforation, and bleeding)
Time Frame
up to 30 days
Title
Non-GI-related composite complications
Description
Both in-hospital and 30-day non-GI-related composite complications (Complication was defined as any deviation from the normal postoperative course or organ dysfunction.[23-25] Organ-specific complications include myocardial infarction, congestive heart failure, cardiac arrest, atrial fibrillation or other types of arrhythmia, pulmonary embolus, pneumonia treated with antibiotics, respiratory failure requiring intubation, respiratory insufficiency requiring physiotherapy or oxygen therapy, stroke, transient ischemic attack, postoperative delirium or cognitive decline, renal insufficiency requiring dialysis, acute kidney injury, urinary tract infection requiring antibiotics, hepatic insufficiency, gut hypoperfusion, ileus, disseminated intravascular coagulation, and sepsis. Surgery-related complications refer to surgical site bleeding, infection, anastomotic leakage, stenosis, ischemia, or tissue necrosis.)
Time Frame
up to 30 days
Title
Length of hospital stay
Description
Length of hospital stay, in days
Time Frame
up to 30 days
Title
Rate of ICU admission
Description
The percentage of patients admitted to ICU after surgery
Time Frame
Up to 30 days
Title
30-day mortality
Description
30-day mortality
Time Frame
30 days
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
It is female patients whom are receiving hysterectomy.
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 18-65 years
Non-smoker
ASA I-III
Elective laparoscopic procedure involving hysterectomy
Exclusion Criteria:
Refuse to participate
Emergent surgery
Bowel resection planned
Vaginal or abdominal (open) hysterectomy
Chemotherapy or radiotherapy before surgery
Significant neuro, cognitive, or psychologic disease: stroke with neurologic deficit, dementia, schizophrenia, or any condition that makes meaningful postoperative follow-ups impossible
Significant cardiovascular disease: low-output cardiac failure defined as a preoperative left ventricular ejection fraction < 30%, active coronary artery disease, symptomatic valvular disease, symptomatic arrhythmia with or without pacemaker and/or AICD placement
Significant pulmonary disease: COPD requiring home oxygen therapy, severe asthma requiring steroid treatment, other pulmonary conditions requiring home oxygen therapy
Severe hepatic dysfunction being evaluated for liver transplantation or with a Child-Pugh Class C classification
Severe renal dysfunction requiring renal replacement therapy
Muscular pathologies such as dystrophy, atrophy, and weakness
Skin conditions incompatible with the adhesive oximetry probe (e.g., delicate or tattooed skin)
Current or previous smoker
ASA Physical Score ≥ IV
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lingzhong Meng, MD
Organizational Affiliation
Yale University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Peking University Third Hospital
City
Beijing
State/Province
Beijing
Country
China
12. IPD Sharing Statement
Plan to Share IPD
Undecided
IPD Sharing Plan Description
Individual participant data are available to the editorial office of the journal to which the manuscript is submitted upon request.
Citations:
PubMed Identifier
27307217
Citation
Geng ZY, Liu YF, Wang SS, Wang DX. Intra-operative dexmedetomidine reduces early postoperative nausea but not vomiting in adult patients after gynaecological laparoscopic surgery: A randomised controlled trial. Eur J Anaesthesiol. 2016 Oct;33(10):761-6. doi: 10.1097/EJA.0000000000000491.
Results Reference
background
PubMed Identifier
7715373
Citation
Gan TJ, Mythen MG. Does peroperative gut-mucosa hypoperfusion cause postoperative nausea and vomiting? Lancet. 1995 Apr 29;345(8957):1123-4. doi: 10.1016/s0140-6736(95)90857-9. No abstract available.
Results Reference
background
PubMed Identifier
28403400
Citation
Meng L, Xiao J, Gudelunas K, Yu Z, Zhong Z, Hu X. Association of intraoperative cerebral and muscular tissue oxygen saturation with postoperative complications and length of hospital stay after major spine surgery: an observational study. Br J Anaesth. 2017 Apr 1;118(4):551-562. doi: 10.1093/bja/aex008.
Results Reference
background
PubMed Identifier
33820562
Citation
Zhao X, Liao K, Wang W, Xu J, Meng L. Can a deep learning model based on intraoperative time-series monitoring data predict post-hysterectomy quality of recovery? Perioper Med (Lond). 2021 Apr 6;10(1):8. doi: 10.1186/s13741-021-00178-4.
Results Reference
derived
Learn more about this trial
Effect of SmtO2 Guided Care on PONV (iMODIPONV)
We'll reach out to this number within 24 hrs